TRCT
GCTK icon

Tower Research Capital (TRC)’s GlucoTrack GCTK Stock Holding History

Tower Research Capital (TRC)’s Portfolio GCTK Stock Details GCTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.24K Buy
3,442
+3,017
+710% +$6.41K ﹤0.01% 4513
2025
Q4 		$1.65K Sell
425
-381
-47% -$2.26K ﹤0.01% 4663
2025
Q3 		$5.31K Sell
806
-966
-55% -$5.82K ﹤0.01% 4246
2025
Q2 		$10.6K Buy
+1,772
New +$15.6K ﹤0.01% 3940
2025
Q1 		– Sell
-1
Closed -$403 – 5410
2024
Q4 		$403 Buy
+1
New +$1.27K ﹤0.01% 5284
2024
Q3 		– Hold
0
– – – 5214
2023
Q1 		– Hold
0
– – – 5976
2022
Q4 		– Hold
0
– – – 6066
2022
Q3 		– Hold
0
– – – 6210
2022
Q2 		– Hold
0
– – – 6219

Other funds holding GCTK

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
AF
Alerus Financial Grand Forks, North Dakota $2.02B AUM 26.03% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
NFSG
Newbridge Financial Services Group Boca Raton, Florida $608M AUM 31.28% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $3.65B AUM 41.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Tower Research Capital (TRC)'s GCTK Position: Q1 2026 in Review

Tower Research Capital (TRC) increased its GlucoTrack (GCTK) stake by 710% in Q1 2026, buying an estimated $6.41K and bringing the position to 3,442 shares worth $2.24K. The position accounts for ﹤0.01% of the portfolio, ranked #4513.

Tower Research Capital (TRC) first reported a position in GCTK in Q4 2024 and has held it in 5 quarters since. The position peaked at $10.6K in Q2 2025. 13 funds tracked by Wall St. Rank hold GCTK as of Q1 2026.

  • Tower Research Capital (TRC) held 3,442 shares of GlucoTrack worth $2.24K as of Q1 2026.
  • Tower Research Capital (TRC) bought 3,017 GlucoTrack shares in Q1 2026, an estimated $6.41K.
  • GlucoTrack made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #4513 holding.
  • Tower Research Capital (TRC) first reported a position in GlucoTrack in Q4 2024 and has held it in 5 quarters since.
  • Tower Research Capital (TRC)'s GlucoTrack position peaked at $10.6K in Q2 2025.
  • 13 funds tracked by Wall St. Rank held GlucoTrack as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.